The impact of home and host country institutional development on multinationals’ r&d intensity

  1. Pia Ellimäki 1
  2. Nuria Esther Hurtado-Torres 1
  3. Eulogio Cordón-Pozo 1
  1. 1 University of Granada, Granada, Spain
Revista:
Business Research Quarterly

ISSN: 2340-9444 2340-9436

Año de publicación: 2024

Volumen: 27

Número: 4

Páginas: 348-364

Tipo: Artículo

DOI: 10.1177/23409444221076495 DIALNET GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: Business Research Quarterly

Resumen

This empirical article examines how the institutional development of the home country and host countries in which multinational enterprises (MNEs) are embedded can drive MNEs’ research and development (R&D) intensity. In doing so, this study analyzes 967 firm-year observations of 234 pharmaceutical firms from 30 developed and less developed countries in the period from 2010 to 2017. We find empirical support for internationalization toward developed countries as a driver of R&D intensity at the firm level. Furthermore, we find that this positive effect is stronger for MNEs from less institutionally developed home countries. The results can help managers, researchers, and policymakers to better understand the innovation process in R&D-intensive industries.

Referencias bibliográficas

  • Aiken, L. S., & West, S. G. (1991). Multiple regression: Testing and interpreting interactions. SAGE.
  • Almeida, P., & Kogut, B. (1999). Location of knowledge and the mobility of engineers in regional networks. Management Science, 45(7), 905–917.
  • Alvarez, R., & Robertson, R. (2004). Exposure to foreign markets and plant-level innovation: Evidence from Chile and Mexico. The Journal of International Trade & Economic Development, 13(1), 57–87.
  • Amankwah-Amoah, J., & Debrah, Y. A. (2017). Toward a construct of liability of origin. Industrial and Corporate Change, 26(2), 211–231.
  • Barslund, M. (2007). CHECKROB: Stata module to perform robustness check of alternative specifications (Statistical Software Components S456837, revised 06 Jun 2018). Boston College Department of Economics.
  • Bartlett, C. A., & Ghoshal, S. (1989). Managing across borders: The transnational solution. Harvard Business School Press.
  • Baum, C. F. (2006). An introduction to modern econometrics using Stata. Stata Press.
  • Berry, H., Guillén, M. F., & Zhou, N. (2010). An institutional approach to cross-national distance. Journal of International Business Studies, 41(9), 1460–1480.
  • Buciuni, G., & Pisano, G. (2021). Variety of innovation in global value chains. Journal of World Business, 56(2), Article 101167.
  • Carney, M., Estrin, S., Liang, Z., & Shapiro, D. (2019). National institutional systems, foreign ownership and firm performance: The case of understudied countries. Journal of World Business, 54(4), 244–257.
  • Cassiman, B., & Golovko, E. (2011). Innovation and internationalization through exports. Journal of International Business Studies, 42(1), 56–75.
  • Castellani, D., Montresor, S., Schubert, T., & Vezzani, A. (2017). Multinationality, R&D and productivity: Evidence from the top R&D investors worldwide. International Business Review, 26(3), 405–416.
  • Chen, W.-R., & Miller, K. D. (2007). Situational and institutional determinants of firms’ R&D search intensity. Strategic Management Journal, 28(4), 369–381.
  • Chen, X., Xue, S., Lv, M., & Wang, R. (2019). Pharmaceutical industry in China: Policy, market and IP. In Innovation, economic development, and intellectual property in India and China (pp. 215–250). Springer, Singapore.
  • Chittoor, R., Aulakh, P. S., & Ray, S. (2015). Accumulative and assimilative learning, institutional infrastructure, and innovation orientation of developing economy firms. Global Strategy Journal, 5(2), 133–153.
  • Choi, Y. R., Yoshikawa, T., Zahra, S. A., & Han, B. H. (2014). Market-oriented institutional change and R&D investments: Do business groups enhance advantage? Journal of World Business, 49(4), 466–475.
  • Cuervo-Cazurra, A. (2011). Global strategy and global business environment: The direct and indirect influences of the home country on a firm’s global strategy. Global Strategy Journal, 1(3–4), 382–386.
  • Cuervo-Cazurra, A. (2012). Extending theory by analyzing developing country multinational companies: Solving the Goldilocks debate. Global Strategy Journal, 2(3), 153–167.
  • Cuervo-Cazurra, A., Ciravegna, L., Melgarejo, M., & Lopez, L. (2018). Home country uncertainty and the internationalizationperformance relationship: Building an uncertainty management capability. Journal of World Business, 53(2), 209–221.
  • Cuervo-Cazurra, A., Doz, Y., & Gaur, A. (2020). Skepticism of globalization and global strategy: Increasing regulations and countervailing strategies. Global Strategy Journal, 20(10), 3–31.
  • Cuervo-Cazurra, A., & Ramamurti, R. (2017). Home country underdevelopment and internationalization: Innovationbased and escape-based internationalization. Competitiveness Review: An International Business Journal, 27(3), 217–230.
  • Cyert, R. M., & March, J. G. (1963). A behavioral theory of the firm. Prentice Hall.
  • Darlington, R. B., & Hayes, A. F. (2017). Regression analysis and linear models. Concepts, applications, and implementation. The Guilford Press.
  • David, P., Yoshikawa, T., Chari, M. D., & Rasheed, A. A. (2006). Strategic investments in Japanese corporations: Do foreign portfolio owners foster underinvestment or appropriate investment? Strategic Management Journal, 27(6), 591–600.
  • Dodgson, M. (2018). Technological collaboration in industry: Strategy, policy and internationalization in innovation. Routledge.
  • Driscoll, J., & Kraay, A. C. (1998). Consistent covariance matrix estimation with spatially dependent data. Review of Economics and Statistics, 80(4), 549–560.
  • Dunning, J. H., & Lundan, S. M. (2008). Institutions and the OLI paradigm of the multinational enterprise. Asia Pacific Journal of Management, 25(4), 573–593.
  • Dziallas, M., & Blind, K. (2019). Innovation indicators throughout the innovation process: An extensive literature analysis. Technovation, 80–81, 3–29.
  • Echambadi, R., & Hess, J. D. (2007). Mean-centering does not alleviate collinearity problems in moderated multiple regression models. Marketing Science, 26(3), 438–445.
  • European Commission. (2020, November 25). Pharmaceutical strategy for Europe. https://ec.europa.eu/health/human-use/ strategy_en
  • Filippetti, A., Frenz, M., & Ietto-Gillies, G. (2017). The impact of internationalization on innovation at countries’ level: The role of absorptive capacity. Cambridge Journal of Economics, 41(2), 413–439.
  • Furman, J. L., Porter, M. E., & Stern, S. (2002). The determinants of national innovative capacity. Research Policy, 31(6), 899–933.
  • Garrido, E., Gomez, J., Maicas, J. P., & Orcos, R. (2014). The institution-based view of strategy: How to measure it. BRQ Business Research Quarterly, 17(2), 82–101.
  • Gassmann, O., Schuhmacher, A., von Zedtwitz, M., & Reepmeyer, G. (2018). Leading pharmaceutical innovation: How to win the life science race. Springer.
  • Golovko, E., & Valentini, G. (2011). Exploring the complementarity between innovation and export for SMEs’ growth. Journal of International Business Studies, 42(3), 362–380.
  • Govindarajan, V., & Ramamurti, R. (2011). Reverse innovation, emerging markets, and global strategy. Global Strategy Journal, 1(3–4), 191–205.
  • Hernandez, E., & Guillén, M. F. (2018). What’s theoretically novel about developing-market multinationals? Journal of International Business Studies, 49(1), 24–33.
  • Herold, D., Jayaraman, N., & Narayanaswamy, C. (2006). What is the relationship between organizational slack and innovation? Journal of Managerial Issues, 18(3), 372–392.
  • Hitt, M. A., Hoskisson, R. E., & Kim, H. (1997). International diversification: Effects on innovation and firm performance in product-diversified firms. Academy of Management Journal, 40(4), 767–798.
  • Hitt, M. A., Tihanyi, L., Miller, T., & Connelly, B. (2006). International diversification: Antecedents, outcomes, and moderators. Journal of Management, 32(6), 831–867.
  • Hoechle, D. (2007). Robust standard error for panel regressions with cross-sectional dependence. The Stata Journal, 7(3), 281–312.
  • Hong, J., Feng, B., Wu, Y., & Wang, L. (2016). Do government grants promote innovation efficiency in China’s high-tech industries? Technovation, 57–58, 4–13.
  • Huang, C. J., & Liu, C. J. (2005). Exploration for the relationship between innovation, IT and performance. Journal of Intellectual Capital, 6(2), 237–252.
  • Kafouros, M. I., Buckley, P. J., Sharp, J. A., & Wang, C. (2008). The role of internationalization in explaining innovation performance. Technovation, 28(1–2), 63–74.
  • Kiriyama, N. (2011). Trade and innovation: Pharmaceuticals (OECD Trade Policy Papers, 113). OECD Publishing.
  • Kostova, T., Roth, K., & Dacin, M. T. (2008). Institutional theory in the study of multinational corporations: A critique and new directions. Academy of Management Review, 33(4), 994–1006.
  • Li, Y., Wei, Z., & Liu, Y. (2010). Strategic orientations, knowledge acquisition, and firm performance: The perspective of the vendor in cross-border outsourcing. Journal of Management Studies, 47(8), 1457–1482.
  • Lu, J. W., & Beamish, P. W. (2004). International diversification and firm performance: The S-curve hypothesis. Academy of Management Journal, 47(4), 598–609.
  • Luo, Y., & Rui, H. (2009). An ambidexterity perspective toward multinational enterprises from emerging economies. Academy of Management Perspectives, 23(4), 49–70.
  • Luo, Y., & Tung, R. L. (2007). International expansion of emerging market enterprises: A springboard perspective. Journal of International Business Studies, 38(4), 481–498.
  • Luo, Y., & Tung, R. L. (2018). A general theory of springboard MNEs. Journal of International Business Studies, 49(2), 129–152.
  • McKinsey & Company. (2017). What’s next for pharma in emerging markets? https://www.mckinsey.com/industries/ pharmaceuticals-and-medical-products/our-insights/whatsnext-for-pharma-in-emerging-markets
  • Meyer, K. E., Estrin, S., Bhaumik, S. K., & Peng, M. W. (2009). Institutions, resources, and entry strategies in emerging economies. Strategic Management Journal, 30(1), 61–80.
  • Meyer, K. E., & Peng, M. W. (2016). Theoretical foundations of emerging economy business research. Journal of International Business Studies, 47(1), 3–22.
  • Nachum, L., & Zaheer, S. (2005). The persistence of distance? The impact of technology on MNE motivations for foreign investment. Strategic Management Journal, 26, 747–767.
  • Neumayer, E., & Plümper, T. (2017). Robustness tests for quantitative research (Methodological tools in the social sciences). Cambridge University Press.
  • Nohria, N., & Gulati, R. (1997). What is the optimum amount of organizational slack?: A study of the relationship between slack and innovation in multinational firms. European Management Journal, 15(6), 603–611.
  • North, D. C. (1990). Institutions, institutional change, and economic performance. Cambridge University Press.
  • OECD. (2018). Executive summary. In Pharmaceutical innovation and access to medicines. OECD Publishing. https://doi. org/10.1787/9789264307391-3-en
  • OECD/EUIPO. (2020). Trade in counterfeit pharmaceutical products, illicit trade. OECD Publishing. https://www. oecd-ilibrary.org/sites/c880184e-en/index.html?itemId=/ content/component/c880184e-en
  • Peng, M. W. (2002). Towards an institution-based view of business strategy. Asia Pacific Journal of Management, 19(2), 251–267.
  • Perlmutter, H. V. (1969). The tortuous evolution of the multinational corporation. Columbia Journal of World Business, 4(1), 9–18.
  • Piperopoulos, P., Wu, J., & Wang, C. (2018). Outward FDI, location choices and innovation performance of emerging market enterprises. Research Policy, 47(1), 232–240.
  • Pisani, N., Garcia-Bernardo, J., & Heemskerk, E. (2020). Does it pay to be a multinational? A large-sample, cross-national replication assessing the multinationality–performance relationship. Strategic Management Journal, 41(1), 152–172.
  • Porter, M. E. (1990). The competitive advantage of nations. Harvard Business Review, 68(2), 73–93.
  • Purkayastha, S., Manolova, T. S., & Edelman, L. F. (2018). Business group effects on the R&D intensity-internationalization relationship: Empirical evidence from India. Journal of World Business, 53(2), 104–117.
  • Ramamurti, R., & Singh, J. V. (2009). Indian multinationals: Generic internationalization strategies. In R. Ramamurti & J. V. Singh (Eds.), Emerging multinationals in emerging markets (pp. 110–166). Cambridge University Press.
  • Ray, S., & Ray, P. K. (2021). Innovation strategy of latecomer firms under tight appropriability regimes: The Indian pharmaceuticals industry. Journal of International Management, 27(1), Article 100820.
  • Rezaie, R., McGahan, A. M., Frew, S. E., Daar, A. S., & Singer, P. A. (2012). Emergence of biopharmaceutical innovators in China, India, Brazil, and South Africa as global competitors and collaborators. Health Research Policy and Systems, 10(1), Article 18.
  • Rosenbusch, N., Gusenbauer, M., Hatak, I., Fink, M., & Meyer, K. E. (2019). Innovation offshoring, institutional context and innovation performance: A meta-analysis. Journal of Management Studies, 56(1), 203–233.
  • Salomon, R. M., & Shaver, J. M. (2005). Learning by exporting: New insights from examining firm innovation. Journal of Economics & Management Strategy, 14(2), 431–460.
  • Sambharya, R. B., & Lee, J. (2014). Renewing dynamic capabilities globally: An empirical study of the world’s largest MNCs. Management International Review, 54(2), 137–169.
  • Santos, J., Doz, Y., & Williamson, P. (2004). Is your innovation process global? MIT Sloan Management Review, 45(4), Article 31.
  • Schaffer, M. E., & Stillman, S. (2006). XTOVERID: Stata module to calculate test of overidentifying restrictions after xtreg, xtivreg, xtivreg2, xthtaylor (Statistical Software Components S456779). Boston College Department of Economics. https://ideas.repec.org/c/boc/bocode/s456779. html
  • Scott, W. R. (1995). Institutions and organizations: Foundations for organizational science. SAGE.
  • Shieh, G. (2011). Clarifying the role of mean centring in multicollinearity of interaction effects. British Journal of Mathematical and Statistical Psychology, 64, 462–477.
  • StataCorp. (2019). Stata Statistical Software: Release 16. StataCorp LLC.
  • Stopford, J. (1998). Multinational corporations. Foreign Policy, 113, 12–24.
  • Thakur-Wernz, P., & Samant, S. (2019). Relationship between international experience and innovation performance: The importance of organizational learning for EMNEs. Global Strategy Journal, 9(3), 378–404.
  • Tsao, S. M., & Lien, W. H. (2013). Family management and internationalization: The impact on firm performance and innovation. Management International Review, 53(2), 189– 213.
  • Tyagi, S., Nauriyal, D. K., & Gulati, R. (2018). Firm level R&D intensity: Evidence from Indian drugs and pharmaceutical industry. Review of Managerial Science, 12(1), 167–202.
  • United Nations Conference on Trade and Development. (2019). Handbook of statistics. United Nations. http://unctadstat. unctad.org
  • Vernon, R. (1979). Foreign production of technology-intensive products by U.S.-based multinational enterprises. National Technical Information Services.
  • Villar, C., Pla-Barber, J., & Ghauri, P. (2020). Learning from foreign operation modes: The virtuous path for innovation. Business Research Quarterly, 23(2), 159–171.
  • Wan, W. P., & Hoskisson, R. E. (2003). Home country environments, corporate diversification strategies, and firm performance. Academy of Management Journal, 46(1), 27–45.
  • Witt, M. A., & Lewin, A. Y. (2007). Outward foreign direct investment as escape response to home country institutional constraints. Journal of International Business Studies, 38(4), 579–594.
  • Wooldridge, J. M. (2013). Introductory econometrics: A modern approach. Cengage Learning/South-Western.
  • World Economic Forum. (2019). The Global Competitiveness Report 2019. http://www3.weforum.org/docs/WEF_ TheGlobalCompetitivenessReport2019.pdf
  • Wu, J. (2013). Diverse institutional environments and product innovation of emerging market firms. Management International Review, 53(1), 39–59.
  • Wu, J., & Park, S. H. (2019). The role of international institutional complexity on emerging market multinational companies’ innovation. Global Strategy Journal, 9(2), 333–353.
  • Wu, J., Wang, C., Hong, J., Piperopoulos, P., & Zhuo, S. (2016). Internationalization and innovation performance of emerging market enterprises: The role of host-country institutional development. Journal of World Business, 51(2), 251–263.
  • Wu, J., & Wu, Z. (2014). Local and international knowledge search and product innovation: The moderating role of technology boundary spanning. International Business Review, 23(3), 542–551.
  • Xie, Z., & Li, J. (2018). Exporting and innovating among emerging market firms: The moderating role of institutional development. Journal of International Business Studies, 49(2), 222–245.
  • Yan, Z. J., Zhu, J. C., Fan, D., & Kalfadellis, P. (2018). An institutional work view toward the internationalization of emerging market firms. Journal of World Business, 53(5), 682–694.
  • Yoo, D., & Reimann, F. (2017). Internationalization of developing country firms into developed countries: The role of host country knowledge-based assets and IPR protection in FDI location choice. Journal of International Management, 23(3), 242–254.
  • Zahra, S. A., Ireland, R. D., & Hitt, M. A. (2000). International expansion by new venture firms: International diversity, mode of market entry, technological learning, and performance. Academy of Management Journal, 43(5), 925–950.
  • Zhao, S., Liu, X., Andersson, U., & Shenkar, O. (2022). Knowledge management of emerging economy multinationals. Journal of World Business, 15, Article 101255.
  • Zhou, K. Z., Gao, G. Y., & Zhao, H. (2017). State ownership and firm innovation in China: An integrated view of institutional and efficiency logics. Administrative Science Quarterly, 62(2), 375–404.
  • Zhou, N., & Guillén, M. F. (2015). From home country to home base: A dynamic approach to the liability of foreignness. Strategic Management Journal, 36(6), 907–917.